课题基金 / 基金详情

Targeting Neurons Involved in Chronic Pain Transmission

Targeting Neurons Involved in Chronic Pain Transmission
针对参与慢性疼痛传播的神经元
批准号:
6344012
负责人:
Douglas A Lappi
金额:
$13.35万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-20 至 2002-09-30

项目摘要

项目成果

Douglas A Lappi的其他基金

相关文献

中文摘要
翻译
描述(改编自申请人的摘要):慢性疼痛是一种巨大的 在美国的问题:据估计,30至1亿人, 通常,目前的治疗方法是无效的, 患者通常被描述为“服务不足”。“根据最近的数据, 慢性疼痛通过表达P物质受体的神经元传递 脊髓背角的一部分这些神经元的消除终止 慢性疼痛信号在几种大鼠模型中的传递。但这 方法依赖于脊髓神经元的死亡。一种替代方法, 维持神经系统的完整性的唯一办法就是 这些神经元的活动。这可以通过内部化 分子进入P物质受体表达神经元,干扰神经元的功能。 传递慢性疼痛信号的能力本一期拟 应用以证明可用于表达的表达系统 能够引起这种破坏的分子,可以内化为P物质, 受体表达神经元,并能表达标记蛋白,绿色荧光 蛋白这一应用的成功可能会导致解决 严重的问题,干扰治疗慢性疼痛。 拟定商业应用: 这一提议将导致开发一种表达系统,用于内部操纵细胞以破坏或改变其功能。这样的系统将在科学研究中有许多应用,不仅在慢性疼痛中,而且在科学家寻求改变细胞过程的任何领域。此外,一种能够减少而不是破坏细胞功能的表达系统在疾病治疗中具有很大的可能性。
英文摘要
DESCRIPTION (Adapted from applicant's abstract): Chronic pain is an enormous problem in the United States: it is estimated that 30 to 100 million people suffer from it. Often, current treatments are ineffective and the population of sufferers is often described as "under-served." According to recent data, chronic pain is transmitted through the Substance P receptor-expressing neurons of the dorsal horn of the spinal cord. Elimination of these neurons terminates transmission of the chronic pain signal in several rat models. However, this method relied on the death of spinal cord neurons. An alternative method that would maintain the integrity of the neuronal system would be to only disrupt the activities of these neurons. This could be achieved by internalizing molecules into Substance P receptor-expressing neurons that interfere with the ability to transmit the chronic pain signal. It is proposed in this Phase I application to demonstrate that an expression system, useful for expressing molecules that can cause this disruption, can be internalized into Substance P receptor-expressing neurons and can express a marker protein, green fluorescent protein. The success of this application could result in the resolution of serious problems that interfere with the treatment of chronic pain. PROPOSED COMMERCIAL APPLICATION: This proposal will result in the development of an expression system for use in internally manipulating cells to disrupt or alter their function. Such a system would have many applications in scientific research, not only in chronic pain, but in any area where scientists seek to alter cell processes. Additionally, an expression system that can diminish rather than destroy a cell's function would have great possibility in the treatment of disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhancing CRISPR-based Therapeutic Interventions Via a Targeted Platform Tool
  • 批准号:
    9253170
  • 项目类别:
  • 资助金额:
    $15.0万
  • 财政年份:
    2017
  • 负责人:
    Douglas A Lappi
  • 依托单位:
Development of a Novel Cancer Pain Therapeutic
  • 批准号:
    7928286
  • 项目类别:
  • 资助金额:
    $300.0万
  • 财政年份:
    2010
  • 负责人:
    Douglas A Lappi
  • 依托单位:
Targeting a Poor Prognosis Marker for Tumor Therapy
  • 批准号:
    7999984
  • 项目类别:
  • 资助金额:
    $15.05万
  • 财政年份:
    2010
  • 负责人:
    Douglas A Lappi
  • 依托单位:
Selective Activation in Specific Neuronal Populations
  • 批准号:
    7538504
  • 项目类别:
  • 资助金额:
    $9.92万
  • 财政年份:
    2009
  • 负责人:
    Douglas A Lappi
  • 依托单位: